Sat.Sep 18, 2021 - Fri.Sep 24, 2021

CDC panel clears way for Pfizer booster shots, but divided on broader use

Bio Pharma Dive

Agency advisers supported giving a third Pfizer vaccine dose to older adults and those with medical conditions. But in a break with the FDA, they voted against recommending it for younger people in high-risk jobs

The hypocrisy of big pharma

World of DTC Marketing

SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. The suggestion by Pfizer’s CEO that drug pricing negotiations with the government would slow innovation is PR doubletalk.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dr. Daniel Pauly’s extraordinary life and work revealed in new book

Scienmag

Daniel Pauly is the world’s most-cited fisheries scientist, but life for the UBC professor has been far from easy. The biracial son of a French woman and an American GI, he was born in Paris and kidnapped as a child to be a live-in servant for a Swiss family. He escaped to Germany at […].

World Pharmacists Day 2021 Celebration

Pharma Mirror

25th September is celebrated as world pharmacists day, and it brings a new theme every year. The main motive behind this celebration is to give an excellent message to improve people’s health worldwide. And also, create an acceptance and encourage the role of a pharmacist in health.

82

'This is the time to double down': Top Vertex executives defend research plan as pressure builds

Bio Pharma Dive

A series of setbacks has led to criticism of the storied biotech's bid to diversify. But Vertex intends to stay the course, its CEO and top scientist say

What is Biogen and can they repair their reputation?

World of DTC Marketing

SUMMARY: If I were to ask you, “what type of company is Biogen?” ” what would be your response? I tried asking that of several colleagues in the industry, and they couldn’t come up with an answer. Biogen has lost its way and is in desperate need of a corporate rebranding.

Scientists show how mucus protein contributes to worsening COPD, asthma, lung conditions

Scienmag

CHAPEL HILL, NC – Mucus is an essential protective layer of gel-like liquid composed largely of proteins called mucins throughout our airways. One of them, called MUC5B, is crucial for the innate defense against the various things we inhale.

More Trending

Novartis pushes further into gene therapy for the eye with deal for Swiss startup

Bio Pharma Dive

The large drugmaker has acquired Arctos Medical and its preclinical research into optogenetics, an area Novartis already showed interest in with its buyout of Vedere Bio last year

Early detection of cancers will require blood sweat and tears

Pharma Phorum

An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell.

Montreal researchers create a novel method of bioprinting neuron cells

Scienmag

A group of researchers including a Concordia PhD student have developed a new method of bioprinting adult neuron cells. They’re using a new laser-assisted technology that maintains high levels of cell viability and functionality.

UK trial to evaluate existing drugs for secondary breast cancer

Pharma Times

Trial will test if radium-223 plus avelumab can improve outcomes for metastatic breast cancer patients

Chinese drugmaker Clover says vaccine prevents COVID-19 in large trial

Bio Pharma Dive

Positive results from Clover's Phase 3 study could mean another coronavirus vaccine option for the many countries still grappling with short supplies

Trials 237

Study finds 10% of medicines in England are overprescribed

Pharma Phorum

An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review.

China launches world’s first early morning meteorological monitoring satellite

Scienmag

A new meteorological satellite, called Fengyun-3E (FY-3E), is crossing the early morning sky, observing and collecting data about the weather, climate and more. Launched by China on July 5, the satellite joined those operated by Europe and the United States orbiting the Earth’s poles.

82

Two Intranasal Candidates Get Closer to Augmenting Pandemic Response

BioSpace

Codagenix Inc. announced positive safety and immunogenicity data from a Phase I dose-escalation trial of its single-dose intranasal COVI-VAC vaccine

Pfizer says coronavirus vaccine is safe and spurs immune response in children

Bio Pharma Dive

The results position Pfizer and BioNTech to seek clearance in children as young as five years old. But the companies haven't yet shared data on a rare heart inflammation associated with their shot that's a concern for regulators

RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare

Pharma Phorum

RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.

96

A 3D printed vaccine patch offers vaccination without a shot

Scienmag

CHAPEL HILL, N.C. Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot. Credit: University of North Carolina at Chapel Hill CHAPEL HILL, N.C.

Llama Nanobodies May be Missing Link in COVID-19 Therapeutics

BioSpace

Monoclonal antibodies play a key role in the treatment of COVID-19, but new research suggests that nanobodies derived from llamas could provide an alternative to monoclonal antibodies

FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans

Bio Pharma Dive

The authorization is more narrow than envisioned by the Biden administration last month, but still makes potentially millions of Americans eligible for a third Pfizer shot

EU panel rejects Pfizer’s tanezumab for osteoarthritis pain

Pharma Phorum

Any lingering hope that Pfizer’s may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor tanezumab looks to have been dashed after the EMA’s human medicines committee rejected the drug.

From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape

Scienmag

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.

Investment in Biopharma is Reaching an Inflection Point

BioSpace

During the past two years, fundraising and investment in biotechnology have reached record levels

95

Insurers sue Merck for 'monopolistic scheme' to delay generics of blockbuster cholesterol drug

Bio Pharma Dive

The suits allege an agreement between Merck and a generic manufacturer kept low-cost versions of the drugmaker's widely used Zetia off the market for years

NHS patients gain access to COVID-19 treatment Ronapreve

Pharma Times

Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19

The benefits of being a family-run pharma company

Pharma Phorum

The third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on the lessons he learned from his father and grandfather – and from his work as a former management consultant – about what it means to run a successful family business and its benefits.

An In-Depth Look at Innovation on Cancer Research Day

BioSpace

September 24 is World Cancer Research Day, a time for patients, caregivers and companies on the forefront of cancer R&D to look back and look ahead

Seagen, Genmab win speedy FDA approval for cervical cancer drug

Bio Pharma Dive

Tivdak, a type of drug known as an antibody-drug conjugate, is the fourth approved medicine for Seagen and its third to reach market since December 2019

Enhertu reduces breast cancer disease progression or death by 72%

Pharma Times

Groundbreaking results' for the treatment of HER2-positive metastatic breast cancer

91

FDA clears AI-powered prostate cancer detection software

Pharma Phorum

Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA. The software – called Paige Prostate – is the first artificial intelligence-based to be approved by the FDA for this purpose, according to the US regulator.

Top 10 US Biopharma Series A Rounds of 2021 – So Far!

BioSpace

The United States has seen companies launching left and right. Check out the top 10 biopharma Series A rounds in the U.S. so far this year

87

Incyte eczema drug wins FDA OK, but with safety warning

Bio Pharma Dive

A topical cream formulation of the drug in Incyte's top-selling product could help the company expand. The black box warning, though, might limit use

Promising early results for new ovarian cancer drug combo

Pharma Times

Drug combination could offer a new option for treatment-resistant advanced ovarian cancer

Drugs 91

Telling it how it is: The need for plain language summaries in medical journals

BioPharma Reporter

Open Pharma wants to see articles in peer-reviewed medical journals provide plain language summaries: those written in everyday language that is easy to understand by anyone from patients to policymakers. It's now set out its recommendations on how to write a good plain language summary.

87

Researchers Turn Back the Clock on Heart Cells in Mice

BioSpace

?Researchers from the Max Planck Institute for Heart and Lung Research reportedly achieved positive results after returning adult cardiomyocytes to their fetal-like state in mouse models

Bluebird officially asks FDA to approve gene therapy for rare blood disorder

Bio Pharma Dive

After several delays, Bluebird has completed an application to the agency to get beti-cel cleared as a treatment for beta-thalassemia

New data demonstrates long-term benefit of Crysvita for XLH patients

Pharma Times

Results showed treatment with Crysvita reduces disease burden for patients

87